1,030
Views
0
CrossRef citations to date
0
Altmetric
Biochemistry, Cell and Molecular Biology, Cancer Biology

MicroRNA-125-5p targets Kruppel-like factor 13 (KLF13) to regulate the proliferation, migration, and invasion of human osteosarcoma cells*

, , , , , , & show all
Pages 236-243 | Received 12 Nov 2020, Accepted 15 Mar 2021, Published online: 29 Mar 2021

References

  • Cao Q, Wang N, Ren L, Tian J, Yang S, Cheng H. 2020. Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas. Cancer Cell Int. 20:1–3.
  • Chen D, Li Y, Su Z, Yu Z, Yu W, Li Y, Gui Y, Yang S, Lai Y. 2015. Identification of miR-125a-5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis. Mol Med Rep. 11(2):1278–1283.
  • Cummins JM, Velculescu VE. 2006. Implications of micro-RNA profiling for cancer diagnosis. Oncogene. 25(46):6220–6227.
  • Guo X, Wu Y, Hartley R. 2009. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 6(5):575–583.
  • Henson BJ, Gollin SM. 2010. Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res. 128(4):192–198.
  • Kumar RMR, Boro A, Fuchs B. 2016. Involvement and clinical aspects of microRNA in osteosarcoma. Int J Mol Sci. 17(6):877.
  • Le XF, Merchant O, Bast RC, Calin GA. 2010. The roles of microRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron. 3(1):137–147.
  • Lee YT, Tan YJ, Oon CE. 2018. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 834:188–196.
  • Liang Y, Ye J, Jiao J, Zhang J, Lu Y, Zhang L, Wan D, Duan L, Wu Y, Zhang B. 2017. Downregulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway. Am J Transl Res. 9(3):1101.
  • Lindsey BA, Markel JE, Kleinerman ES. 2017. Osteosarcoma overview. Rheumatology and Therapy. 4(1):25–43.
  • Mirabello L, Troisi RJ, Savage SA. 2009. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 125(1):229–234.
  • Picci P. 2007. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis. 2(1):6.
  • Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. 2016. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 6(3):235–246.
  • Sadykova LR, Ntekim AI, Muyangwa-Semenova M, Rutland CS, Jeyapalan JN, Blatt N, Rizvanov AA. 2020 May 11. Epidemiology and risk factors of osteosarcoma. Cancer Investig. 38(5):259–269.
  • Song C, Wu G, Xiang A, Zhang Q, Li W, Yang G, Shi XE, Sun S, Li X. 2015. Overexpression of miR-125a-5p inhibits proliferation in C2C12 myoblasts by targeting E2F3. Acta Biochim Biophys Sin. 47(4):244–249.
  • Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Yuan W. 2018. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 17(1):147.
  • Tan W, Liu B, Qu S, Liang G, Luo W, Gong C. 2018 Mar 1. MicroRNAs and cancer: Key paradigms in molecular therapy. Oncol Lett. 15(3):2735–2742.
  • Tao T, Shen Q, Luo J, Xu Y, Liang W. 2017. MicroRNA-125a regulates cell proliferation via directly targeting E2F2 in osteosarcoma. Cell Physiol Biochem. 43(2):768–774.
  • Vienberg S, Geiger J, Madsen S, Dalgaard LT. 2017. MicroRNAs in metabolism. Acta Physiol. 219(2):346–361.
  • Wang F, Sun GP, Zou YF, Hao JQ, Zhong F, Ren WJ. 2012. MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark. 11(6):259–267.
  • Wu R, Yun Q, Zhang J, Bao J. 2019. Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion. Onco Targets Ther. Volume 12:1509–1520.
  • Yang M, Tang X, Wang Z, Wu X, Tang D, Wang D. 2019 Dec 20. miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ. Biosci Rep. 39(12).BSR20190193.
  • Zeng Y. 2006. Principles of micro-RNA production and maturation. Oncogene. 25(46):6156–6162.
  • Zeng J, Li YK, Quan FF, Zeng X, Chen CY, Zeng T, Zou J, Tong WJ. 2020. Propofol–induced miR–125a–5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B. Mol Med Rep. 22(2):1507–1517.
  • Zha Z, Li J. 2020 Nov. MicroRNA–125a–5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1. Int J Mol Med. 46(5):1849–1861.
  • Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. 2018. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4. Biomed Pharmacother. 108:1039–1047.
  • Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L, Luo X, Huang X, Li J, Chen S, Shen N. 2010. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62(11):3425–3435.